USC Scientists Discover How to Create a Never-Ending Supply of Cancer-Fighting Cells
What Happened?
Researchers at USC have developed a method to produce a renewable supply of cancer-fighting immune cells. This breakthrough could enhance cancer immunotherapy by overcoming challenges in cell production and activity.
Key points
- USC scientists discovered a method to produce renewable cancer-fighting immune cells.
- The research focuses on granulocyte-monocyte progenitors (GMPs), which can develop into effective immune cells.
- Experiments showed that engineered GMPs slowed cancer progression in mice.
- The study suggests GMPs can self-renew, challenging previous beliefs about immune cell development.
- The engineered cells could potentially be used in treatments for various conditions beyond cancer.
Key insights
- The ability to produce GMPs in large quantities may revolutionize cancer immunotherapy.
- This method could allow for off-the-shelf treatments, making therapies more accessible.
- The findings may lead to advancements in treating inherited immune deficiencies.
Why it matters
This discovery could lead to more effective cancer treatments and a better understanding of immune cell development.
Tags
Entities
Source
Science Daily
